Clinical Trial

Immunotherapy: Care and Prevention of Infectious and Tumoral Diseases (ImmunoHUB)

Name: Immunotherapy: Care and Prevention of Infectious and Tumoral Diseases (ImmunoHUB) — clinical trial record (NCT06914635)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The project comprises two research lines. In the line 1, human monoclonal antibodies toward SARS-CoV-2 will be generate and characterized by in vitro functional tests. In the line 2, in vitro tests will be performed to evaluate the efficency of immune response mediated by antibodies direct to specific tumor molecules.

Trial Details

NCT Number	NCT06914635
Lead Sponsor	Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions	SARS CoV-2, Liver Tumours
Enrollment	40 participants
Start Date	2023-05-30
Primary Completion	2025-02-19 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2025-04-06